Ghost Tree Capital, LLC Rapt Therapeutics, Inc. Transaction History

Ghost Tree Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$16.28 - $24.6 $569,800 - $861,000	35,000 Added 38.89%	125,000 $2.48 Million
Q3 2022 Nov 14, 2022	SELL	$17.96 - $30.46 $1.35 Million - $2.28 Million	-75,000 Reduced 45.45%	90,000 $2.17 Million
Q2 2022 Aug 15, 2022	SELL	$10.26 - $23.59 $872,100 - $2.01 Million	-85,000 Reduced 34.0%	165,000 $3.01 Million
Q1 2022 May 16, 2022	SELL	$17.02 - $40.22 $1.7 Million - $4.02 Million	-100,000 Reduced 28.57%	250,000 $5.5 Million
Q4 2021 Feb 16, 2022	BUY	$29.5 - $39.5 $2.95 Million - $3.95 Million	100,000 Added 40.0%	350,000 $12.9 Million
Q3 2021 Nov 15, 2021	SELL	$29.86 - $39.47 $9.56 Million - $12.6 Million	-320,000 Reduced 56.14%	250,000 $7.76 Million
Q2 2021 Aug 11, 2021	BUY	$17.99 - $40.02 $10.3 Million - $22.8 Million	570,000 New	570,000 $18.1 Million
Q4 2020 Feb 16, 2021	SELL	$15.89 - $40.87 $1.83 Million - $4.7 Million	-115,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$21.6 - $37.5 $2.48 Million - $4.31 Million	115,000 New	115,000 $3.7 Million

105

27.1M

26.7K

2.4K

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $35.6M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.